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ABSTRACT
Objective: Image-guided core needle biopsy (IGCNB) is
an accepted technique for sampling nonpalpable mam-
mographically detected suspicious breast lesions.
However, the concern for needle-track seeding in malig-
nant lesions remains. An alternative to IGCNB is needle-
localization breast biopsy (NLBB). No study has been
done to compare the local recurrence rate of breast can-
cer after IGCNB versus NLBB.
Methods: We  have retrospectively reviewed the local
recurrence of breast cancer in patients diagnosed by
either IGCNB or NLBB who underwent breast-preserving
treatment for their cancer between May 1990 and June
1995. The length of follow-up averaged 29.7 months.
Results: Three hundred ninety-eight patients were diag-
nosed with breast cancer by IGCNB (297 patients) or
NLBB (101 patients). All patients underwent breast-con-
serving surgery. Fifteen (3.77%) patients had a local
recurrence: 11(3.70%) in the IGCNB group and 4 (3.96%)
in the NLBB group. These recurrence rates are not statis-
tically different.
Conclusion: Concerns for seeding of the needle track
with cancer cells have made some surgeons wary of
IGCNB. However, we did not find an increased rate of
recurrence due to needle-track seeding, and IGCNB
remains our procedure of choice for diagnosing mam-
mographically detected suspicious breast lesions.
Key Words: Image-guided core needle biopsy, Breast
cancer, Mammography.
INTRODUCTION
Image-guided breast biopsy via core needle biopsy
(IGCNB) is an accurate and cost-efficient technique for
sampling nonpalpable breast lesions detected mammo-
graphically. Image-guided core needle biopsy has
replaced needle localization breast biopsy (NLBB) as our
procedure of choice in sampling these suspicious, non-
palpable mammographic lesions. The advantages of
IGCNB versus NLBB have been well documented.1-3
Image-guided core needle biopsy is minimally invasive
and has favorable cosmetic results. It is much less costly
than surgical biopsy. In addition, IGCNB can be set up
and performed quickly, and patients are able to return to
their usual activities immediately after the procedure.
Despite its strengths, many surgeons still express con-
cern for malignant seeding of the needle track during
IGCNB. Harter et al3 have reported the only known case
in the literature. In this case, a stereotactic core needle
biopsy was performed that showed mucinous infiltrating
ductal carcinoma. Two weeks following IGCNB, the
patients underwent wide local excision of the biopsy
site. An area of firmness in the surgical specimen demon-
strated early organizing hemorrhage with associated
macrophages, which is consistent with a healing needle
track. Within the track were several nests of mucinous
carcinoma cells.
To definitively attribute a local recurrence of breast cancer
to seeding from a needle track, one would have to prove
that the needle track was left behind and then demonstrate
microscopic evidence of cancer cells in the needle track. It
would be impossible for us to demonstrate that for the 398
patients in our study. Therefore, we assume that local
recurrence in the breast is a possible indicator of needle-
track recurrence. As such, the incidence of needle-track
recurrence should be lower than the total incidence of
local recurrence of breast cancer.
At present, no study has been done to assess the local
recurrence rate of breast cancer after IGCNB versus
NLBB. We have retrospectively reviewed the local recur-
rence of breast cancer in patients diagnosed by either
IGCNB or NLBB who underwent breast-preserving treat-
ment for their cancer. We expected no difference in the
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local recurrence rate of breast cancer, demonstrating the
safety of the IGCNB technique regarding this concern.
MATERIALS AND METHODS
Between May 1990 and June 1995, 398 patients were
diagnosed with breast cancer by IGCNB (297) or NLBB
(101) (Table 1). Image-guided core needle biopsies were
performed with a Bard 23-mm automated core biopter
with a 14-gauge needle under stereotactic or ultrasound
guidance. Needle localizations were performed free-hand
with grid-guided placement of the hook-wire. All patients
subsequently had breast-conserving therapy with
lumpectomy with axillary dissection, radiation therapy, or
both (Table 2). Patients were followed for a mean of 29.7
months (range 2 to 90 months). The data were analyzed
with Fischer’s exact test. No specific attempt was made to
excise the biopsy needle track at the definitive surgery;
however, we recognize that the track was excised in
many cases.
RESULTS
Fifteen (3.77%) of 398 patients had local recurrence of
their breast cancer: eleven (3.70%) of 297 in the IGCNB
group and 4 (3.96%) of 101 in the NLBB group. These
recurrence rates are not statistically significant (p = 1.0).
Local recurrence of breast cancer in the setting of breast-
conserving therapy with radiation ranges from 4% to 10%
over 12 years.4-6 However, most local recurrences occur
within 24 months. Our recurrence rates for patients who
did not undergo radiation therapy were 12.5% for
lumpectomy alone and 1.6% for lumpectomy with axil-
lary dissection. The difference in this recurrence rate is
not statistically significant (p = 0.68) and is most likely
due to the small sample size. For patients who had radi-
ation therapy, the local recurrence rate totaled 3.51%.
Our data objectively demonstrate that IGCNB does not
have an increased rate of local recurrence due to seed-
ing of the needle track compared with NLBB.
DISCUSSION
Image-guided core needle biopsy is our favored method
for sampling nonpalpable but suspicious mammograph-
ic lesions. Concern for cancer seeding of the needle track
has made some clinicians wary of this technique, but our
data do not support this fear. The potential exists for
Table 1.
Diagnostic Modalities and Recurrence Rates
Diagnostic Modality* Number of Patients Number of Local Recurrences Local Recurrence Rate
IGCNB 297 11 3.70%
NLBB 101 4 3.96%
TOTAL 398 15 3.77%
*IGCNB = image-guided core needle breast biopsy; NLBB = needle localization breast biopsy.
Table 2.
Treatment Modalities and Recurrence Rates
Treatment Modality* Number of Patients Number of Local Recurrences Local Recurrence Rate
Lump 24 3 12.5%
Lump-ax 61 1 1.6%
Lump-XRT 32 0 0%
Lump-ax-XRT 281 11 3.91%
Total 398 15 3.77%
*Lump = lumpectomy, ax = axillary node dissection, XRT = radiation therapy.seeding after any penetration of a malignancy, whether it
be image-guided core needle biopsy, needle-localization
breast biopsy, or fine-needle aspiration.7 Following
breast-conserving therapy for cancer, radiation therapy
should destroy any malignant cells remaining in a needle
track. On occasion, the needle track may be excised with
the lumpectomy specimen. Image-guided core needle
biopsy is favored for its high sensitivity (>90%),1 low
cost, time efficiency, cosmetic results, and minimal mor-
bidity.
CONCLUSION
We conclude that IGCNB does not have an increased risk
for needle-track seeding compared with NLBB, and
IGCNB remains our procedure 
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